Nuestro sitio web utiliza cookies para mejorar y personalizar su experiencia y para mostrar anuncios (si los hay). Nuestro sitio web también puede incluir cookies de terceros como Google Adsense, Google Analytics, Youtube. Al usar el sitio web, usted consiente el uso de cookies. Hemos actualizado nuestra Política de Privacidad. Por favor, haga clic en el botón para consultar nuestra Política de Privacidad.

Investments and Business

Musk threatens Apple and calls OpenAI boss a liar as feud deepens

Tech feud deepens as Musk threatens Apple and calls OpenAI’s Altman a liar

The intensifying public clash among Elon Musk, Apple, and OpenAI has reached new heights, driven by allegations and legal warnings. Musk, who owns X and launched the AI enterprise xAI, has openly blamed Apple for what he describes as "unambiguous antitrust breach" due to its alleged preference for OpenAI's ChatGPT within its App Store. He warned of taking swift legal measures against the tech behemoth. This audacious assertion was made via a sequence of updates on his social media network, where he also openly confronted OpenAI CEO Sam Altman, labeling him a "deceiver" and reviving their longstanding hostility. The rivalry…
Leer Más
Trump is promising to slash drug prices by 1,500%. Here’s what’s really happening

Breaking down Trump’s 1,500% drug price reduction promise

Former President of the United States, Donald Trump, is once more in the spotlight following a daring promise: to reduce prescription drug costs by an incredible 1,500%. This statement has stirred enthusiasm among his followers and ignited discussions across various political arenas. However, the magnitude of the figure has prompted numerous experts, commentators, and regular citizens to ponder over the feasibility, mathematical validity, and potential implementation of such a proposal. At face value, the promise is eye-catching. Drug prices have been a persistent source of frustration for millions of Americans, with rising costs affecting not only patients but also insurers,…
Leer Más
US and China agree to critical extension, preventing tariff surge on the world’s two largest economies

US and China settle on key extension, preventing tariff rise for major economies

The United States and China have finalized a crucial deal that will prolong important trade agreements, thereby preventing a potentially destabilizing rise in tariffs between the globe's two largest economies. This decision occurs as international markets have been attentively observing each update in the economic dynamics between Washington and Beijing, with worries that intensifying trade actions might disturb supply networks, elevate expenditures for buyers, and further pressure an already delicate global economy. The choice to prolong the existing terms indicates an uncommon instance of collaboration between the two economic giants, whose connection in recent times has been characterized by strain,…
Leer Más
Companies are monitoring and enforcing office attendance at the highest rate in 5 years

Companies reach new 5-year peak in enforcing office attendance

Corporate America is currently experiencing a notable transformation in how workplaces are managed, with companies intensifying their focus on tracking and enforcing attendance in the office. Recent information indicates that organizations are overseeing employee attendance more diligently than they have since 2019, signifying a stark contrast to the flexible remote work arrangements that were prevalent during the pandemic period. Este resurgimiento en el seguimiento de la asistencia a la oficina representa un esfuerzo más amplio por parte de las empresas para regularizar las disposiciones laborales presenciales. Compañías de diferentes sectores están adoptando sistemas de monitoreo avanzados que van más allá…
Leer Más